I led a net-new eligibility tool end to end. The hard part was never a screen, it was the logic: dozens of coverage scenarios, resolved within the real limits of checking insurance remotely.
The payoff: a plain-language coverage verdict, the real cost of each medication, and the plan it recommends, all keyed to what the person's insurance actually covers.
People do not know whether their insurance covers GLP-1s, and that uncertainty stalls high-intent users at the door. The project had also stalled internally before I picked it up and drove it to launch.
The craft was not a single screen, it was the eligibility logic behind it. I accounted for a wide range of user situations and coverage outcomes, worked within the real limits of checking coverage remotely, and designed every plan so each person left with a result they could act on. Balancing the user's need, an honest answer, and the technical limits was the work.
I owned the content outline for the public landing page and partnered with the WordPress team to build it. It sets up the promise, shows how the check works, and brings people into the tool.
Good, partial, and no coverage are three of a wider range the logic had to resolve. Whatever the outcome, the design leads with a plain-language verdict, then the recommended program and the real cost, so no one hits a dead end.
Swipe through the coverage-report variants
The coverage-report variants. Swipe between them and scroll any report end to end, from the verdict through the medication costs to the recommended plan.
Inside every report, the branded medications show up as cards: covered, prior-auth required, or not covered, each with the real copay or cash price. People see exactly what a given GLP-1 would cost them before they commit to anything.
The medication cost cards, scrollable. Each one carries the coverage status and the real monthly cost for a specific medication, keyed to what the person's plan actually covers.
The whole experience at a glance: landing page, confidence questions, insurance details, clinical eligibility, the coverage check, and every result and plan-page variant the logic routes to.
The tool cleared 1.5 LTV:CAC on a new, price-sensitive segment, and roughly half of everyone who saw a coverage report started the buyflow. The known leak is survey drop-off, which is the next thing to fix.
The win was making an intimidating insurance moment feel like guidance, and getting the logic right so every scenario still ended somewhere useful. Clear routing beat more copy.